Episode Details

In this episode, we explore when and why long-acting injectable antipsychotics (LAIs) should be considered for patients with schizophrenia, covering approved indications, ideal candidate profiles, and the critical role of shared decision-making in treatment planning.

Faculty: Brian Miller, M.D., Ph.D., M.P.H.
Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 0.75 CME: Use of Long-Acting Injectable Antipsychotics in Schizophrenia
• Understanding When to Prescribe LAIs